Ge Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ge Li has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Shi Chen
Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China
14 shared publications - Cai-Feng Lin
Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China
13 shared publications - Cheng-Ke Xie
Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China
13 shared publications - Cheng-Yu Liao
Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China
13 shared publications - Hao-Xiang Zhang
Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China
13 shared publications - Hong-Yi Lin
Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China
13 shared publications
Latest Publications
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Table S1 Baseline characteristics of necrosis foci in clinical PDAC samples
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Table S1 Baseline characteristics of necrosis foci in clinical PDAC samples
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S2 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S2 The identification of the necroptosis-regulating lncRNA TRAF3IP2-AS1 in PDAC
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S2 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S2 The identification of the necroptosis-regulating lncRNA TRAF3IP2-AS1 in PDAC
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S1 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S1 The cell marker for cell type definition and the flowchart of PDOX model construction.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S1 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S1 The cell marker for cell type definition and the flowchart of PDOX model construction.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S4 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S4 TRAF3IP2-AS1 deficiency-induced necroptosis promotes M2-like macrophage polarization through the release of TGFβ1
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S4 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S4 TRAF3IP2-AS1 deficiency-induced necroptosis promotes M2-like macrophage polarization through the release of TGFβ1
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S5 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S5 In co-culture with macrophages, TRAF3IP2-AS1 deficiency-induced necroptosis promotes the enhancement of EMT via the secretion of TGFβ1.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S5 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S5 In co-culture with macrophages, TRAF3IP2-AS1 deficiency-induced necroptosis promotes the enhancement of EMT via the secretion of TGFβ1.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Data from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid malignancies. PDAC is characterized by prominent necrotic foci within the tumor and a high propensity for distant liver metastasis, leading to a poor prognosis. In this study, using patient-derived organoid models, single-cell RNA sequencing, and multiplex immunofluorescence staining of samples from patients with PDAC, in vivo TGFβ1 conditional knockout mouse models, and 3D in vitro models, we discovered that the formation of intratumoral necrotic foci in pancreatic cancer is closely associated with liver metastatic events. This process was triggered by the deficiency of the long noncoding RNA TRAF3IP2-AS1 that induced necroptosis, which was accompanied by an immunosuppressive microenvironment. Mechanistically, TRAF3IP2-AS1 blocked necroptosis by reducing the mRNA stability of MLKL through competitively binding to IGF2BP2. Loss of TRAF3IP2-AS1 also promoted necroptosis by promoting RIPK3 phosphorylation via interference with the ubiquitination of the phosphatase PPM1B that dephosphorylates RIPK3. Additionally, TRAF3IP2-AS1 deficiency promoted the release of TGFβ1 from tumor cells, which induced an M2-like immunosuppressive phenotype and the release of more TGFβ1. The elevated production of TGFβ1 created a feedback loop that promoted the transcription of TRAF3IP2-AS1 in tumor cells to balance necroptosis. Overall, these findings identify TRAF3IP2-AS1 as a key regulator of necroptosis and the formation of an immunosuppressive microenvironment in PDAC, providing potential therapeutic targets for treating liver metastasis in patients with pancreatic cancer.Significance:TRAF3IP2-AS1 deficiency drives necroptosis in pancreatic cancer cells to engender a prometastatic immunosuppressive niche mediated by TGFβ1 production, providing mechanistic understanding of necroptosis and therapeutic strategies for treating liver metastasis.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid malignancies. PDAC is characterized by prominent necrotic foci within the tumor and a high propensity for distant liver metastasis, leading to a poor prognosis. In this study, using patient-derived organoid models, single-cell RNA sequencing, and multiplex immunofluorescence staining of samples from patients with PDAC, in vivo TGFβ1 conditional knockout mouse models, and 3D in vitro models, we discovered that the formation of intratumoral necrotic foci in pancreatic cancer is closely associated with liver metastatic events. This process was triggered by the deficiency of the long noncoding RNA TRAF3IP2-AS1 that induced necroptosis, which was accompanied by an immunosuppressive microenvironment. Mechanistically, TRAF3IP2-AS1 blocked necroptosis by reducing the mRNA stability of MLKL through competitively binding to IGF2BP2. Loss of TRAF3IP2-AS1 also promoted necroptosis by promoting RIPK3 phosphorylation via interference with the ubiquitination of the phosphatase PPM1B that dephosphorylates RIPK3. Additionally, TRAF3IP2-AS1 deficiency promoted the release of TGFβ1 from tumor cells, which induced an M2-like immunosuppressive phenotype and the release of more TGFβ1. The elevated production of TGFβ1 created a feedback loop that promoted the transcription of TRAF3IP2-AS1 in tumor cells to balance necroptosis. Overall, these findings identify TRAF3IP2-AS1 as a key regulator of necroptosis and the formation of an immunosuppressive microenvironment in PDAC, providing potential therapeutic targets for treating liver metastasis in patients with pancreatic cancer.Significance:TRAF3IP2-AS1 deficiency drives necroptosis in pancreatic cancer cells to engender a prometastatic immunosuppressive niche mediated by TGFβ1 production, providing mechanistic understanding of necroptosis and therapeutic strategies for treating liver metastasis.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S3 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S3 TRAF3IP2-AS1 deficiency leads to necroptosis in PDAC.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S3 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S3 TRAF3IP2-AS1 deficiency leads to necroptosis in PDAC.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S7 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S7 TRAF3IP2-AS1 deficiency regulates PPM1B ubiquitination through TRAF3IP2
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S7 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S7 TRAF3IP2-AS1 deficiency regulates PPM1B ubiquitination through TRAF3IP2
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Table S2 Characteristics of the organoids in the In-House Cohort
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Table S2 Characteristics of the organoids in the In-House Cohort
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S6 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S6 IGF2BP2 augments the stability of MLKL mRNA via the m6A pathway
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S6 from TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
Supplementary Fig. S6 IGF2BP2 augments the stability of MLKL mRNA via the m6A pathway